A 56-year-old woman presented to our hospital service with headache and neck and shoulder pain. She was eventually diagnosed with antiphospholipid syndrome and monoclonal immunoglobulinaemia of unknown significance (MGUS). The Treponema pallidum (TP) particle agglutination assay (TPPA) and syphilis toluidine red unheated serum test (TRUST) were positive with TPPA 1:20 480 and TRUST 1:131 072. HIV and hepatitis tests were negative. Previous medical history included four miscarriages for unknown causes. No skin rash or other abnormalities suggestive of syphilis were observed. Her spouse was healthy and showed negative syphilis serology. There were no other partners. Based on a diagnosis of latent syphilis, she was given the recommended penicillin therapy. However, after three courses of treatment, the TRUST titre was 1:32 768, and the TPPA titre remained unchanged with 1:20 480. TP IgM was positive by immunoblotting, whereas ELISA IgG anti-TP assays (TP-ELISA) and the fluorescent treponemal antibody absorbed test (FTA-ABS) and blood TP-nested PCR were negative. Further investigations showed a normal cerebrospinal fluid (CSF) with negative TPPA and TRUST, and unremarkable brain MRI, abdominal ultrasound scan and Doppler echocardiography. Hence, we considered the possibility of false-positive syphilis TPPA and TRUST results associated with antiphospholipid syndrome and MGUS.
False-positive non-specific syphilis serology (TRUST/venereal disease research laboratory test) can be caused by various diseases, especially autoimmune diseases like antiphospholipid syndrome.1 In addition, plasma cell diseases such as multiple myeloma and macroglobulinaemia can lead to false-positive tests, but titres are usually low, and TP/specific tests (TPPA/TP-ELISA/FTA-ABS) are negative.2 Unusually in this case, both TPPA and TRUST titres were significantly higher than previously reported.
Footnotes
Handling editor: Anna Maria Geretti
G-LL, X-YZ and R-JD contributed equally.
Collaborators: no.
Contributors: GL conducted the study and wrote all draft supported by XZ, RD, Y-KC, RAA and Y-YL. XZ and Y-KC completed some serological tests of syphilis. RD collected and sorted out the clinical data of the patient. All authors were involved in drafting and finalising the paper. All authors read and approved the final manuscript.
Funding: This work was supported in part by the Project of AIDS Bureau of Yunnan Province, the “Ten-thousand Talents Programme” of Yunnan Province(YNWR-MY-2018–039), the Medical Leadership Foundation of Health and Family Planning Commission of Yunnan Province, China (L-201613), the Yunnan Province Clinical Research Center for Skin Immune Diseases (2019ZF012), and the Yunnan Province Clinical Centre for Skin Immune Diseases (ZX2019-03-02).
Competing interests: None declared.
Provenance and peer review: Not commissioned; internally peer reviewed.
Ethics statements
Patient consent for publication
Not required.
Ethics approval
Not applicable.
References
- 1. Asherson RA, Davidge-Pitts MC, Wypkema E. "Primary" antiphospholipid syndrome evolving into Waldenstrom's macroglobulinaemia: a case report. Clin Rheumatol 2007;26:278–80. 10.1007/s10067-005-0144-7 [DOI] [PubMed] [Google Scholar]
- 2. He T-J, Mo F, Xiao X-Y, et al. [Relationship between M-Protein of Multiple Myeloma and False Positive Syphilis Serological Results]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016;24:478–81. 10.7534/j.issn.1009-2137.2016.02.032 [DOI] [PubMed] [Google Scholar]